Evidence map›Paper›PMID 37144361›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Predicting Pediatric Tuberculosis: The Need for Age-Specific Host Biosignatures.

Sara Suliman, Devan Jaganath, Andrew DiNardo

Abstract readEditorialComment
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Sara SulimanDepartment of Medicine, Division of Experimental Medicine, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-5154-576X
Devan JaganathDivision of Pediatric Infectious Diseases, University of California San Francisco, San Francisco, California, USA.
Andrew DiNardoGlobal TB Program, Center for Human Immunbiology, Baylor College of Medicine, Houston, Texas, USA.

Funding

Childhood Omics and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settingsR01AI152161 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CATTAMANCHI, ADITHYA, ERNST, JOEL D. · 2020 to 2024
$7.6M
Host Proteomic Biosignatures for a Urine-based Diagnosis of Pulmonary Tuberculosis in ChildrenK23HL153581 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JAGANATH, DEVAN · 2020 to 2024
$946k
NHLBI NIH HHS K23 HL153581NIAID NIH HHS R01 AI152161
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fetal BloodTuberculosisAge FactorsBiomarkersBirth CohortCase-Control StudiesChildChild, PreschoolGene ExpressionHumansSouth AfricaBiomarkers

Identifiers

PMID37144361
PMCPMC10425193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.